Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - SHORT-TERM DEBT
Short-term Debt RNAZ - TransCode Therapeutics, Inc.
412 K
LAST VALUE
0.00%
2 YEAR CAGR
63.13%
5 YEAR CAGR
0.00%
10 YEAR CAGR